scholarly article | Q13442814 |
P50 | author | Martin Leach | Q42070326 |
P2093 | author name string | Brada M | |
Dzik-Jurasz AS | |||
Rowland IJ | |||
Murphy PS | |||
Viviers L | |||
P2860 | cites work | In vivo 1H NMR spectroscopy of an intracerebral glioma in the rat. | Q31082382 |
Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging | Q34496845 | ||
Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications | Q39495167 | ||
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas | Q40135518 | ||
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. | Q40978170 | ||
Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain | Q43632743 | ||
In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement | Q43765198 | ||
Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors | Q44263995 | ||
In vivo measurement of the size of lipid droplets in an intracerebral glioma in the rat. | Q47217270 | ||
Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. | Q48190907 | ||
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance | Q48401235 | ||
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study | Q48619667 | ||
Good practice in the management of adults with malignant cerebral glioma: clinical guidelines. Working Group, Royal College of Physicians | Q48641248 | ||
Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. | Q48784804 | ||
N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues | Q48800486 | ||
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. | Q49104638 | ||
Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method. | Q55478971 | ||
Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours. | Q55480785 | ||
P433 | issue | 907 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 459-463 | |
P577 | publication date | 2003-07-01 | |
P1433 | published in | British Journal of Radiology | Q15758529 |
P1476 | title | Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? | |
P478 | volume | 76 |
Q33273666 | A metabolomics perspective of human brain tumours |
Q31061313 | Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. |
Q33622591 | Chemical shift-based water/fat separation: a comparison of signal models |
Q30764446 | Clinical proton MR spectroscopy in central nervous system disorders |
Q30989929 | Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making |
Q64062838 | Elevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case report |
Q54935926 | Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours. |
Q44916216 | In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post-processing and metabolite quantification at 14.1 T. |
Q34033507 | In vivo characterization of several rodent glioma models by 1H MRS |
Q35738941 | Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts |
Q50581029 | Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy. |
Q36575246 | Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours |
Q31144824 | Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience |
Q48961414 | Neuroradiological assessment of newly diagnosed glioblastoma |
Q46502407 | Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma |
Q46663930 | Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent |
Q46350291 | Role of advanced MR imaging modalities in diagnosing cerebral gliomas |
Q41931195 | ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. |